The truncated isoform of somatostatin receptor5 (sst5TMD4) is associated with poorly differentiated thyroid cancer

JUSTO PASTOR CASTAÑO FUENTESRAUL MIGUEL LUQUE HUERTASMANUEL DAVID GAHETE ORTIZ2026-01-292026-01-29201410.1371/journal.pone.00855272-s2.0-84908105505https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/25666MultidisciplinaryThe truncated isoform of somatostatin receptor5 (sst5TMD4) is associated with poorly differentiated thyroid cancerresearch article